Overview
Global venture-capital firm investing from early stage through growth in technology-led companies. Its biotechnology portfolio includes AI-enabled drug discovery, microbiome, cell and gene therapies, small molecules and radiopharmaceuticals.
Unlock the full profileGet the complete company dossier
This public view only shows an extract. Open the full profile to access the complete company intelligence record, including the full write-up and structured research details.